Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedMay 28, 2026
DataAggregated Company Financials
Companies9
  • 7D-0.3%
  • 3M3.0%
  • 1Y-13.8%
  • YTDn/a

AddLife is up 0.3%, leading the way for the Clinical Research and Equipment industry, which has gained 2.3%. In the past year, the industry is down 13%. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 28 May 2026SEK 29.8bSEK 14.6b-SEK 849,175,077.0037x-35.1x2x
Sat, 25 Apr 2026SEK 29.8bSEK 14.6b-SEK 971,664,077.0034.5x-30.7x2x
Mon, 23 Mar 2026SEK 26.3bSEK 14.6b-SEK 838,374,077.0031.2x-31.4x1.8x
Wed, 18 Feb 2026SEK 26.8bSEK 14.9b-SEK 553,301,427.0032.3x-48.3x1.8x
Fri, 16 Jan 2026SEK 30.0bSEK 14.9b-SEK 744,515,427.0047.4x-40.3x2x
Sun, 14 Dec 2025SEK 32.9bSEK 14.9b-SEK 744,515,427.0054.5x-44.2x2.2x
Tue, 11 Nov 2025SEK 34.7bSEK 14.7b-SEK 748,598,012.0058.1x-46.4x2.4x
Thu, 09 Oct 2025SEK 35.1bSEK 14.7bSEK 61.3m58.4x572.7x2.4x
Sat, 06 Sep 2025SEK 34.9bSEK 14.7bSEK 60.9m56.4x573.1x2.4x
Mon, 04 Aug 2025SEK 35.8bSEK 14.8bSEK 158.0m61.3x226.3x2.4x
Wed, 02 Jul 2025SEK 46.5bSEK 16.6bSEK 416.3m68.5x111.7x2.8x
Fri, 30 May 2025SEK 45.6bSEK 16.6bSEK 404.2m72.3x112.9x2.7x
Sun, 27 Apr 2025SEK 43.1bSEK 16.6bSEK 642.3m44.1x67.1x2.6x
Tue, 25 Mar 2025SEK 36.9bSEK 16.6bSEK 614.3m39x60.1x2.2x
Thu, 20 Feb 2025SEK 44.0bSEK 17.0b-SEK 1,033,505,426.0043.3x-42.6x2.6x
Sat, 18 Jan 2025SEK 39.1bSEK 16.7b-SEK 1,152,911,426.0042.2x-33.9x2.3x
Mon, 16 Dec 2024SEK 44.1bSEK 16.7b-SEK 1,152,911,426.0050.4x-38.3x2.6x
Wed, 13 Nov 2024SEK 44.2bSEK 16.8b-SEK 948,072,426.0050.3x-46.6x2.6x
Fri, 11 Oct 2024SEK 46.5bSEK 16.7b-SEK 988,175,491.0057.2x-47.1x2.8x
Sun, 08 Sep 2024SEK 47.4bSEK 16.7b-SEK 988,176,492.0059.9x-48x2.8x
Tue, 06 Aug 2024SEK 46.3bSEK 16.7b-SEK 1,128,120,510.0058.2x-41x2.8x
Thu, 04 Jul 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0054.2x-35.5x2.6x
Sat, 01 Jun 2024SEK 43.6bSEK 16.3b-SEK 1,188,686,510.0062.9x-36.7x2.7x
Mon, 29 Apr 2024SEK 37.7bSEK 16.2b-SEK 1,246,589,705.0036.2x-30.2x2.3x
Wed, 27 Mar 2024SEK 40.4bSEK 16.0b-SEK 1,122,792,210.0034.6x-36x2.5x
Fri, 23 Feb 2024SEK 39.3bSEK 16.0b-SEK 1,119,170,478.0043x-35.1x2.5x
Sun, 21 Jan 2024SEK 35.8bSEK 15.5b-SEK 1,393,723,683.0042.9x-25.7x2.3x
Tue, 19 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0045.3x-27.4x2.5x
Thu, 16 Nov 2023SEK 32.3bSEK 15.4b-SEK 1,256,647,710.0036.3x-25.7x2.1x
Sat, 14 Oct 2023SEK 24.0bSEK 15.1b-SEK 1,134,516,711.0033.5x-21.2x1.6x
Mon, 11 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.8x-25.8x1.9x
Wed, 09 Aug 2023SEK 31.8bSEK 15.1b-SEK 213,871,038.0045.7x-148.5x2.1x
Fri, 07 Jul 2023SEK 35.6bSEK 14.6b-SEK 172,476,038.0039x-206.2x2.4x
Sun, 04 Jun 2023SEK 40.0bSEK 14.6b-SEK 172,476,038.0039.5x-231.7x2.7x
Price to Earnings Ratio

-231.7x


Total Market Cap: SEK 40.0bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 16.7x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market1.32%
Healthcare0.80%
Life Sciences-0.29%
Clinical Research and Equipment-0.29%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRO PromimicSEK 14.1017.5%
+SEK 39.7m		-21.4%PS5.4x
GENO Genovis AB (publ.)SEK 20.501.2%
+SEK 16.5m		-23.9%PE55.7x
IDLDX IDL DiagnosticsSEK 0.4811.3%
+SEK 11.3m		-15.1%PS2x
ATANA AttanaSEK 0.00716.7%
+SEK 2.6m		-75.0%PS4.5x
LEVBIO Level BioSEK 0.3110.6%
+SEK 2.1m		-29.1%PS0.6x

Latest News

MAGLE
SEK 3.56
Magle Chemoswed Holding
7D
-13.2%
1Y
-87.6%
PRO
SEK 14.10
Promimic
7D
17.5%
1Y
-21.4%
LEVBIO
SEK 0.31
Level Bio
7D
10.6%
1Y
-29.1%
ATANA
SEK 0.007
Attana
7D
16.7%
1Y
-75.0%
IDLDX
SEK 0.48
IDL Diagnostics
7D
11.3%
1Y
-15.1%
MCAP
SEK 530.00
MedCap
7D
-4.7%
1Y
22.1%
ALIF B
SEK 144.40
AddLife
7D
-3.5%
1Y
-21.3%
BICO
SEK 18.54
BICO Group
7D
-2.1%
1Y
-47.4%
GENO
SEK 20.50
Genovis AB (publ.)
7D
1.2%
1Y
-23.9%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%